| Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group PY Wen, DR Macdonald, DA Reardon, TF Cloughesy, AG Sorensen, ... Journal of clinical oncology 28 (11), 1963-1972, 2010 | 4012 | 2010 |
| Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial PD Brown, K Jaeckle, KV Ballman, E Farace, JH Cerhan, SK Anderson, ... Jama 316 (4), 401-409, 2016 | 1519 | 2016 |
| Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC· 3): a multicentre, randomised, controlled … PD Brown, KV Ballman, JH Cerhan, SK Anderson, XW Carrero, ... The Lancet Oncology 18 (8), 1049-1060, 2017 | 1045 | 2017 |
| Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study E Galanis, JC Buckner, MJ Maurer, JI Kreisberg, K Ballman, J Boni, ... Journal of Clinical Oncology 23 (23), 5294-5304, 2005 | 834 | 2005 |
| Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ... Neuro-oncology 22 (8), 1073-1113, 2020 | 702 | 2020 |
| Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ... Neuro-oncology 17 (9), 1188-1198, 2015 | 644 | 2015 |
| Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress TC Liu, E Galanis, D Kirn Nature clinical practice Oncology 4 (2), 101-117, 2007 | 559 | 2007 |
| Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data JN Sarkaria, LS Hu, IF Parney, DH Pafundi, DH Brinkmann, NN Laack, ... Neuro-oncology 20 (2), 184-191, 2018 | 555 | 2018 |
| Extrapulmonary small cell carcinoma E Galanis, S Frytak, RV Lloyd Cancer: Interdisciplinary International Journal of the American Cancer …, 1997 | 437 | 1997 |
| Targeting angiogenesis: progress with anti-VEGF treatment with large molecules A Grothey, E Galanis Nature reviews Clinical oncology 6 (9), 507-518, 2009 | 430 | 2009 |
| Hepatic Arterial Infusion of a Replication-selective Oncolytic Adenovirus (dl1520) Phase II Viral, Immunologic, and Clinical Endpoints T Reid, E Galanis, J Abbruzzese, D Sze, LM Wein, J Andrews, B Randlev, ... Cancer research 62 (21), 6070-6079, 2002 | 413 | 2002 |
| Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study E Galanis, KA Jaeckle, MJ Maurer, JM Reid, MM Ames, JS Hardwick, ... Journal of clinical oncology 27 (12), 2052, 2009 | 401 | 2009 |
| Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme C Giannini, JN Sarkaria, A Saito, JH Uhm, E Galanis, BL Carlson, ... Neuro-oncology 7 (2), 164-176, 2005 | 373 | 2005 |
| Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer E Galanis, LC Hartmann, WA Cliby, HJ Long, PP Peethambaram, ... Cancer research 70 (3), 875-882, 2010 | 356 | 2010 |
| Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial T Reid, E Galanis, J Abbruzzese, D Sze, J Andrews, L Romel, M Hatfield, ... Gene therapy 8 (21), 1618-1626, 2001 | 320 | 2001 |
| Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme LK Phuong, C Allen, KW Peng, C Giannini, S Greiner, CJ TenEyck, ... Cancer research 63 (10), 2462-2469, 2003 | 298 | 2003 |
| Intraperitoneal therapy of ovarian cancer using an engineered measles virus KW Peng, CJ TenEyck, E Galanis, KR Kalli, LC Hartmann, SJ Russell Cancer research 62 (16), 4656-4662, 2002 | 279 | 2002 |
| Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model EK Mader, Y Maeyama, Y Lin, GW Butler, HM Russell, E Galanis, ... Clinical Cancer Research 15 (23), 7246-7255, 2009 | 233 | 2009 |
| Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results E Galanis, JC Buckner, RP Dinapoli, BW Scheithauer, RB Jenkins, ... Journal of neurosurgery 89 (3), 425-430, 1998 | 225 | 1998 |
| Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study BB Friday, SK Anderson, J Buckner, C Yu, C Giannini, F Geoffroy, ... Neuro-oncology 14 (2), 215-221, 2011 | 221 | 2011 |
